News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
178,106 Results
Type
Article (31933)
Company Profile (14)
Press Release (146159)
Section
Business (54782)
Career Advice (373)
Deals (3885)
Drug Delivery (9)
Drug Development (24695)
Employer Resources (34)
FDA (3383)
Job Trends (3316)
News (85039)
Policy (4854)
Tag
Academia (2397)
Alliances (11549)
Alzheimer's disease (473)
Approvals (3375)
Artificial intelligence (30)
Bankruptcy (27)
Best Places to Work (2763)
Biotechnology (20)
Breast cancer (44)
Cancer (319)
Cardiovascular disease (29)
Career advice (342)
Cell therapy (60)
Clinical research (18754)
Collaboration (87)
COVID-19 (1193)
C-suite (66)
Cystic fibrosis (19)
Data (377)
Diabetes (31)
Diagnostics (1659)
Earnings (7382)
Employer resources (30)
Events (18642)
Executive appointments (206)
FDA (3489)
Funding (99)
Gene therapy (47)
GLP-1 (116)
Government (1050)
Healthcare (5407)
Infectious disease (1209)
Inflammatory bowel disease (30)
Interviews (42)
IPO (1728)
Job creations (615)
Job search strategy (321)
Layoffs (31)
Legal (968)
Lung cancer (43)
Manufacturing (22)
Medical device (3141)
Medtech (3142)
Mergers & acquisitions (2175)
Metabolic disorders (79)
Neuroscience (533)
NextGen Class of 2024 (1917)
Non-profit (1814)
Northern California (383)
Obesity (34)
Opinion (26)
Patents (20)
People (32254)
Phase I (5936)
Phase II (8651)
Phase III (5672)
Pipeline (86)
Postmarket research (979)
Preclinical (3104)
Press Release (25)
Radiopharmaceuticals (70)
Rare diseases (51)
Real estate (1373)
Regulatory (3130)
Research institute (1371)
Resumes & cover letters (23)
Southern California (294)
Startups (1127)
United States (2930)
Vaccines (181)
Weight loss (18)
Date
Today (34)
Last 7 days (222)
Last 30 days (828)
Last 365 days (8104)
2024 (7321)
2023 (9750)
2022 (12140)
2021 (13961)
2020 (13516)
2019 (13165)
2018 (9777)
2017 (9045)
2016 (9228)
2015 (10648)
2014 (8091)
2013 (7832)
2012 (7782)
2011 (7854)
2010 (7239)
Location
Africa (263)
Arizona (37)
Asia (10306)
Australia (2581)
California (762)
Canada (475)
China (57)
Colorado (38)
Connecticut (40)
Europe (27288)
Florida (86)
Georgia (26)
Illinois (93)
Indiana (41)
Japan (20)
Maryland (104)
Massachusetts (463)
Michigan (20)
Minnesota (44)
New Jersey (198)
New York (224)
North Carolina (209)
Northern California (383)
Ohio (48)
Pennsylvania (175)
South America (293)
Southern California (294)
Texas (112)
Washington State (89)
178,106 Results for "columbia university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sable Therapeutics Announces Exclusive Worldwide Licensing Agreement with Columbia University to Develop Novel Polycation Nanomedicines for the Treatment of Obesity
August 12, 2024
·
2 min read
Policy
PreveCeutical Commences Litigation Against Former Legal Counsel in the British Columbia Supreme Court Alleging Professional Negligence
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”), announces that it, along with certain others, filed a Notice of Civil Claim (the “Claim”) in the British Columbia Supreme Court on June 5, 2024 against its former legal counsel (the “Defendants”).
June 6, 2024
·
5 min read
Business
NRx Pharmaceuticals Announces Signing of a Data and Technical Information Agreement with Columbia University Accessing Key Data Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatment of Suicidal Depression
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced that it has signed a License Data and Technical Information Agreement with Columbia University for rights to data from a randomized, active-controlled trial of 80 patients hospitalized for Acute Suicidality in Depression.
December 19, 2023
·
4 min read
Drug Development
ElmediX Plans Series A Round Based on Strong Signals in a Clinical Study for Pancreatic Cancer Patients at the University Hospital Antwerp (Belgium)
Earlier this year, scientists from Columbia University in New York demonstrated that the growth rate of pancreatic cancer, measured in patients’ blood using CA19-9 as biomarker, determines survival chances and can be used as a quick way to assess treatment effectiveness.
June 14, 2024
·
3 min read
Altasciences Completes Expansion of New State-Of-The-Art Laboratory in Columbia, Missouri
Altasciences is pleased to announce the completion of its laboratory facilities in Columbia, MO.
October 31, 2023
·
2 min read
Cell MedX Corp. Announces Full Revocation of British Columbia Cease Trade Order
Cell MedX Corp. (“Cell MedX” or the “Company”) (OTC Pink: CMXC) announces that on November 22, 2023, the British Columbia Securities Commission
November 28, 2023
·
4 min read
Business
Thylacine Biotherapeutics Licenses Novel Antiviral Peptide Platform from Columbia University
Thylacine Biotherapeutics Inc. (“Thylacine Bio”), a privately held biotech company dedicated to combating infectious disease, announced today it has entered into a license agreement with Columbia University (“Columbia”) for worldwide exclusive rights to develop and commercialize a novel antiviral peptide platform.
February 14, 2023
·
2 min read
Press Releases
Aspect Biosystems Announces $200 Million Partnership with the Governments of Canada and British Columbia to Advance Development of Bioprinted Tissue Therapeutics
July 23, 2024
·
3 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
1 of 17,811
Next